Multiple Sclerosis Trial, Recruiting (NCT05177523)

Multiple Sclerosis Trial, Recruiting NCT05177523 Sponsor: University Hospital, Basel, Switzerland Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT05177523 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Multiple Sclerosis (MS):

People diagnosed with active relapsing-remitting MS (RRMS), meaning they have had more than one relapse or shown signs of new MS activity on a brain scan in the past year
People diagnosed with progressive MS (either primary or secondary progressive) that is not currently active, meaning no relapses or new scan activity in the past year
People aged between 18 and 80 years old
People who do not have any other neurological or psychiatric conditions

For healthy volunteers (people without MS):

People aged between 18 and 80 years old
People who do not have any other neurological or psychiatric conditions

Who may not be able to join:

People who are pregnant
People who are unable to have an MRI scan, for example due to claustrophobia, metal implants in the body, or a pacemaker (confirm with trial site for other possible reasons)
People who are not able to give their own informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cristina Granziera, Prof. Dr. med., Department of Neurology, University Hospital Basel

Phone: +41 61-32 85 665

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05177523

Sponsor: University Hospital, Basel, Switzerland

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +41 61-32 85 665

More information: https://clinicaltrials.gov/study/NCT05177523

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with Multiple Sclerosis (MS):

People diagnosed with active relapsing-remitting MS (RRMS), meaning they have had more than one relapse or shown signs of new MS activity on a brain scan in the past year
People diagnosed with progressive MS (either primary or secondary progressive) that is not currently active, meaning no relapses or new scan activity in the past year
People aged between 18 and 80 years old
People who do not have any other neurological or psychiatric conditions

For healthy volunteers (people without MS):

People aged between 18 and 80 years old
People who do not have any other neurological or psychiatric conditions

Who may not be able to join:

People who are pregnant
People who are unable to have an MRI scan, for example due to claustrophobia, metal implants in the body, or a pacemaker (confirm with trial site for other possible reasons)
People who are not able to give their own informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Basel, Switzerland

Registry

ClinicalTrials.gov

Start date

4 September 2018

Est. completion

1 December 2028

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

MRI- change in axonal integrity and organization over 2 years in aMS, naPMS and HC, by using machine learning techniques

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov